Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting crawled time : 12:01 save search
Intra-Cellular Therapies Announces CAPLYTA Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
ITCI 1 d | $72.29 0.4% 0.4% 2.2M
|
Health Technology
|
| O: 0.81%
H: 1.82%
C: -0.88%
caplyta meeting
Enlivex Selected for an Elevator Pitch Presentation and two additional Poster Presentations at the 2023 Annual Meeting of the International Society for Cell & Gene Therapy
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
ENLV | $1.4 -4.23% 110K
|
Health Technology
|
| O: -1.14%
H: 1.15%
C: 0.77%
presentation international cell meeting therapy
Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Jefferies Healthcare Conference June 7-8, 2023
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
ICPT | $19.0 -0.05% 4M
|
Health Technology
|
| O: -2.79%
H: 5.25%
C: 0.67%
conference pharmaceuticals
The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
TOI | $1.2 -2.44% -2.5% 38K
|
|
| O: 0.05%
H: 11.66%
C: 0.92%
institute asco meeting
ACG Announces Results of Annual General Meeting of Shareholders
Published: 2020-12-18 (Crawled : 12:01) - globenewswire.com
AACG | $0.94 -8.74% -9.57% 11K
|
Commercial Services
|
| O: -1.69%
H: 3.47%
C: 3.47%
results
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome
Published: 2020-12-15 (Crawled : 12:01) - globenewswire.com
AVXL | News | $3.8 0.0% 2.1M
|
Health Technology
|
| O: 20.42%
H: 2.08%
C: -4.16%
life science trial phase 2 anavex®2-73 anavex syndros rett syndrome
HEXO Corp announces results of its annual and special meeting of shareholders
Published: 2020-12-14 (Crawled : 12:01) - globenewswire.com
HEXO | $0.71 -0.14% 310K
|
Process Industries
|
| O: 10.0%
H: 0.0%
C: -8.18%
results
uniQure Presents Late-Breaking Data from the HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B at the 62nd Annual Meeting of the American Society of Hematology
Published: 2020-12-08 (Crawled : 12:01) - globenewswire.com
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
|
| O: 2.09%
H: 1.15%
C: -1.53%
therapy gene therapy trial gene therapies
TG Therapeutics Recaps Schedule of Data Presentations at the Upcoming 62nd American Society of Hematology Annual Meeting and Exposition
Published: 2020-12-03 (Crawled : 12:01) - globenewswire.com
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: 0.04%
H: 2.8%
C: 2.36%
FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual Meeting
Published: 2020-12-02 (Crawled : 12:01) - globenewswire.com
FGEN | $1.15 -1.71% -1.74% 1.3M
|
Health Technology
|
| O: -0.32%
H: 3.62%
C: 2.15%
phase 3
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.